Cargando…

Correlation between COVID-19 severity and previous exposure of patients to Borrelia spp.

Predictors for the risk of severe COVID-19 are crucial for patient care and control of the disease. Other infectious diseases as potential comorbidities in SARS-CoV-2 infection are still poorly understood. Here we identify association between the course of COVID-19 and Lyme disease (borreliosis), ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Szewczyk-Dąbrowska, Alina, Budziar, Wiktoria, Harhala, Marek, Baniecki, Krzysztof, Pikies, Aleksandra, Jędruchniewicz, Natalia, Kaźmierczak, Zuzanna, Gembara, Katarzyna, Klimek, Tomasz, Witkiewicz, Wojciech, Nahorecki, Artur, Barczyk, Kamil, Kłak, Marlena, Grata-Borkowska, Urszula, Dąbrowska, Krystyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509370/
https://www.ncbi.nlm.nih.gov/pubmed/36153350
http://dx.doi.org/10.1038/s41598-022-20202-x
Descripción
Sumario:Predictors for the risk of severe COVID-19 are crucial for patient care and control of the disease. Other infectious diseases as potential comorbidities in SARS-CoV-2 infection are still poorly understood. Here we identify association between the course of COVID-19 and Lyme disease (borreliosis), caused by Borrelia burgdorferi transmitted to humans by ticks. Exposure to Borrelia was identified by multi-antigenic (19 antigens) serological testing of patients: severe COVID-19 (hospitalized), asymptomatic to mild COVID-19 (home treated or not aware of being infected), and not infected with SARS-CoV-2. Increased levels of Borrelia-specific IgGs strongly correlated with COVID-19 severity and risk of hospitalization. This suggests that a history of tick bites and related infections may contribute to the risks in COVID-19. Though mechanisms of this link is not clear yet, screening for antibodies targeting Borrelia may help accurately assess the odds of hospitalization for SARS-CoV-2 infected patients, supporting efforts for efficient control of COVID-19.